Upload Image (Max 20MB per Image)
Novogen, a biotechnology company, has announced the filing of a family of provisional patents in the US covering anti-tropomyosin (ATM) drug technology. ATM drugs represent an entirely novel approach to anti-cancer therapy, blocking the ...
Tags: Health, Medicine, Anti-Tropomyosin Drug Technology